Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase II Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced or Metastatic Gastrointestinal Cancers (X7-7)

Summary

The purpose of this phase II study is compare different doses of capecitabine to see if one is better than the other in terms of efficacy and toxicity.

General Information

NCT#: NCT02595320
Study ID: 2015-X7-7-LQT
Trial Phase: Phase II

Trial Sponsor: University of Kansas Medical Center
Therapies Used in This Trial: Capecitabine

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search